| 注册
首页|期刊导航|青岛大学学报(医学版)|西地那非口崩片在中国健康受试者中的生物等效性

西地那非口崩片在中国健康受试者中的生物等效性

周雨石 秦如斋 易德平 林金水 陈学义 谢志红

青岛大学学报(医学版)2025,Vol.61Issue(6):813-819,7.
青岛大学学报(医学版)2025,Vol.61Issue(6):813-819,7.DOI:10.11712/jms.2096-5532.2025.61.191

西地那非口崩片在中国健康受试者中的生物等效性

Bioequivalence of sildenafil citrate orally disintegrating tablets in healthy Chinese subjects

周雨石 1秦如斋 1易德平 2林金水 2陈学义 3谢志红1

作者信息

  • 1. 广州医科大学附属第二医院Ⅰ期临床试验中心、广州医科大学药学院,广东 广州 510260
  • 2. 中润药业有限公司
  • 3. 北京阳光德美医药科技有限公司
  • 折叠

摘要

Abstract

Objective To investigate the bioequivalence of the test and reference products of sildenafil citrate orally disinte-grating tablets in healthy Chinese subjects in a fasting state.Methods This single-center,randomized,open-label,two-treat-ment,two-sequence,two-period,crossover study was conducted among 36 healthy adult male subjects.The subjects received the test product or the reference product of sildenafil citrate orally disintegrating tablets at a dose of 50 mg in each period,with a 5-day washout between treatments.A validated high-performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS)method was used to measure the plasma concentrations of sildenafil and its major metabolite N-desmethyl sildenafil.The non-com-partmental analysis was performed for plasma concentration data.Phoenix WinNonlin 8.2 was used to calculate pharmacokinetic pa-rameters,and SAS 9.4 was used to perform bioequivalence analysis.Results After the administration of the test and reference products,the peak concentration(Cmax)of sildenafil was 252.00±104.00 μg/L and 255.00±90.70 μg/L,respectively,with an area under the plasma concentration-time curve from time 0 to the time of last measurement(AUC0-t)of 694.41±269.29 μg·h/L and 687.71±247.19 μg·h/L,respectively,and an area under the plasma concentration-time curve from time 0 extrapolated to in-finity(AUC0-∞)of 705.21±272.18 μg·h/L and 699.43±251.85 μg·h/L,respectively.The Cmax of N-desmethyl sildenafil was 94.00±32.70 μg/L and 96.10±38.80 μg/L,respectively,with an AUC0-t of 322.52±121.29 μg·h/L and 331.33±145.82 μg·h/L,respectively,and an AUC0-∞ of 333.93±127.15 μg·h/L and 345.09±159.03 μg·h/L,respectively.The geometric mean ra-tios of Cmax,AUC0-t,and AUC0-∞ for the two formulations of sildenafil were 97.36%(95%CI=89.03%-106.47%),100.18%(95%CI=96.57%-103.92%),and 100.08%(95%CI=96.51%-103.77%),respectively,and the geometric mean ratios of Cmax,AUC0-t,and AUC0-∞ for the two formulations of N-desmethyl sildenafil were 98.84%(95%CI=92.14%-106.25%),98.54%(95%CI=95.87%-101.28%),and 98.23%(95%CI=95.45%-101.09%),respectively.All these results were within the bioequivalence acceptance range of 80.00%—125.00%.Con-clusion The test and reference products of sildenafil citrate orally disintegrating tablets are bioequivalent in healthy Chinese sub-jects,with a good safety profile.

关键词

枸橼酸西地那非/药代动力学/生物等效性/血药浓度/健康受试者

Key words

sildenafil citrate/pharmacokinetics/bioequivalency/plasma concentration/healthy volunteers

分类

医药卫生

引用本文复制引用

周雨石,秦如斋,易德平,林金水,陈学义,谢志红..西地那非口崩片在中国健康受试者中的生物等效性[J].青岛大学学报(医学版),2025,61(6):813-819,7.

基金项目

广东省医学科学技术研究基金(B2023146) (B2023146)

青岛大学学报(医学版)

1672-4488

访问量0
|
下载量0
段落导航相关论文